PCN1- BASELINE ANEMIA AND RISK OF POOR RESPONSE TO CHEMOTHERAPY IN INTERMEDIATE GRADE NON-HODGKINS LYMPHOMA(IGNHL) PATIENTS
Sep 1, 2001, 00:00 AM
10.1016/S1098-3015(11)71561-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)71561-3/fulltext
Section Title :
Section Order :
75
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71561-3&doi=10.1016/S1098-3015(11)71561-3